Group One Trading
BLRX

Group One Trading’s BioLineRX BLRX Stock Holding History

Group One Trading’s Portfolio BLRX Stock Details BLRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-200
Closed -$756 – 8162
2025
Q3 		$756 Sell
200
-200
-50% -$802 ﹤0.01% 8098
2025
Q2 		$1.83K Buy
+400
New +$1.48K ﹤0.01% 7434
2024
Q2 		– Sell
-253
Closed -$11.3K – 6738
2024
Q1 		$11.3K Buy
253
+148
+141% +$7.42K ﹤0.01% 5801
2023
Q4 		$6.59K Sell
105
-78
-43% -$4.83K ﹤0.01% 6402
2023
Q3 		$13.3K Buy
183
+178
+3,560% +$12K ﹤0.01% 6171
2023
Q2 		$319 Buy
+5
New +$277 ﹤0.01% 7421
2022
Q2 		– Sell
-8
Closed -$1K – 7826
2022
Q1 		$1K Sell
8
-10
-56% -$696 ﹤0.01% 7803
2021
Q4 		$1K Buy
18
+5
+38% +$521 ﹤0.01% 7965
2021
Q3 		$1K Buy
13
+8
+160% +$949 ﹤0.01% 8003
2021
Q2 		$1K Buy
+5
New +$588 ﹤0.01% 7998

Other funds holding BLRX

XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
RhumbLine Advisers
RhumbLine Advisers Boston, Massachusetts $117B AUM 29.66% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
NRG
Nemes Rush Group Novi, Michigan $1.05B AUM 30.08% 1-Year Est. Return
NA
NewEdge Advisors New Orleans, Louisiana $27.7B AUM 22.98% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Group One Trading's BLRX Position: Q2 2025 in Review

Group One Trading sold out of BioLineRX (BLRX) in Q2 2025, closing a stake of 79 shares — an estimated $292 sold.

Group One Trading first reported a position in BLRX in Q3 2021 and held it in 10 quarters. The position peaked at $22K in Q4 2021. 17 funds tracked by Wall St. Rank hold BLRX as of Q2 2025.

  • Group One Trading reported no remaining BioLineRX position as of Q2 2025 after selling out during the quarter.
  • Group One Trading sold 79 BioLineRX shares in Q2 2025, an estimated $292.
  • Group One Trading first reported a position in BioLineRX in Q3 2021 and held it in 10 quarters.
  • Group One Trading's BioLineRX position peaked at $22K in Q4 2021.
  • 17 funds tracked by Wall St. Rank held BioLineRX as of Q2 2025.

Based on Group One Trading's 13F filing for Q2 2025, filed 14 Aug 2025.